Literature DB >> 4019732

Genetic analysis in families with van der Woude syndrome.

A B Burdick, D Bixler, C L Puckett.   

Abstract

We have brought together information on 864 affected individuals in 164 families (including three new pedigrees) reported in the 137 year period since 1845 when Demarquay first described a family with what was later called van der Woude syndrome (VWS). Both types of oral cleft, cleft palate (CP) and cleft lip with or without CP (CLP), segregate in these families together with lower lip pits or fistulae in an autosomal dominant mode with high penetrance estimated to be K = .89 and .99 by different methods. Cleft types (CLP and CP) occur in VWS in the same proportions as in the general non-VWS population, ie, about twice as many cleft-bearing individuals have CLP as have CP. On the other hand, we do not find the usually observed excess of females with CP and excess of males with CLP; in VWS the sex ratios are more nearly equal. Lip pits also are equally distributed between the sexes. Affected males and females are equally likely to transmit VWS. However, there is an excess of less severely affected individuals among transmitters and a deficiency of more severely affected, brought about by a proband bias and differential fecundity. The expression of VWS is significantly modified by the genetic background: More extreme phenotypes in parents tend to produce more extreme expression in their children. For a VWS gene carrier the relative risk of transmitting a cleft is 26.45%; that of transmitting lower lip pits is 23.55%. Three pedigrees of lip pits in the literature show no clefts among a significant number of affected individuals. Control of gene expression in VWS in the three target tissues appears to be independent and separately designated. Mutation rate of the VWS gene is calculated to be 1.8 X 10(-5).

Entities:  

Mesh:

Year:  1985        PMID: 4019732

Source DB:  PubMed          Journal:  J Craniofac Genet Dev Biol        ISSN: 0270-4145


  23 in total

1.  A preliminary gene map for the Van der Woude syndrome critical region derived from 900 kb of genomic sequence at 1q32-q41.

Authors:  B C Schutte; B C Bjork; K B Coppage; M I Malik; S G Gregory; D J Scott; L M Brentzell; Y Watanabe; M J Dixon; J C Murray
Journal:  Genome Res       Date:  2000-01       Impact factor: 9.043

2.  Surgical, Speech, and Audiologic Outcomes in Patients With Orofacial Cleft and Van der Woude Syndrome.

Authors:  Spencer Kitchin; Lynn Grames; Sybill D Naidoo; Gary Skolnick; Alyssa Schoenborn; Alison Snyder-Warwick; Kamlesh Patel
Journal:  J Craniofac Surg       Date:  2019-07       Impact factor: 1.046

3.  An etiologic regulatory mutation in IRF6 with loss- and gain-of-function effects.

Authors:  Walid D Fakhouri; Fedik Rahimov; Catia Attanasio; Evelyn N Kouwenhoven; Renata L Ferreira De Lima; Temis Maria Felix; Larissa Nitschke; David Huver; Julie Barrons; Youssef A Kousa; Elizabeth Leslie; Len A Pennacchio; Hans Van Bokhoven; Axel Visel; Huiqing Zhou; Jeffrey C Murray; Brian C Schutte
Journal:  Hum Mol Genet       Date:  2014-01-16       Impact factor: 6.150

4.  MCS9.7 enhancer activity is highly, but not completely, associated with expression of Irf6 and p63.

Authors:  Walid D Fakhouri; Lindsey Rhea; Tianli Du; Eileen Sweezer; Harris Morrison; David Fitzpatrick; Baoli Yang; Martine Dunnwald; Brian C Schutte
Journal:  Dev Dyn       Date:  2011-11-23       Impact factor: 3.780

5.  Face facts: genes, environment, and clefts.

Authors:  J C Murray
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

6.  Association of transforming growth-factor alpha gene polymorphisms with nonsyndromic cleft palate only (CPO).

Authors:  R Shiang; A C Lidral; H H Ardinger; K H Buetow; P A Romitti; R G Munger; J C Murray
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

7.  The Van der Woude syndrome (dominantly inherited lip pits and clefts).

Authors:  A Schinzel; M Kläusler
Journal:  J Med Genet       Date:  1986-08       Impact factor: 6.318

8.  Dominant mutations in GRHL3 cause Van der Woude Syndrome and disrupt oral periderm development.

Authors:  Myriam Peyrard-Janvid; Elizabeth J Leslie; Youssef A Kousa; Tiffany L Smith; Martine Dunnwald; Måns Magnusson; Brian A Lentz; Per Unneberg; Ingegerd Fransson; Hannele K Koillinen; Jorma Rautio; Marie Pegelow; Agneta Karsten; Lina Basel-Vanagaite; William Gordon; Bogi Andersen; Thomas Svensson; Jeffrey C Murray; Robert A Cornell; Juha Kere; Brian C Schutte
Journal:  Am J Hum Genet       Date:  2013-12-19       Impact factor: 11.025

Review 9.  Toward an orofacial gene regulatory network.

Authors:  Youssef A Kousa; Brian C Schutte
Journal:  Dev Dyn       Date:  2015-09-17       Impact factor: 3.780

10.  Linkage of Van der Woude syndrome (VWS) to REN and exclusion of the candidate gene TGFB2 from the disease locus in a large pedigree.

Authors:  A Sander; H Moser; S Liechti-Gallati; T Grimm; M Zingg; J Raveh
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.